(Q35193442)

7 August 2017

1 reference

title

Can nonliving nasal vaccines be made to work? (English)

1 reference

7 August 2017

Bjørn Haneberg

1

1 reference

PubMed ID

12901561

7 August 2017

Johan Holst

series ordinal

2

1 reference

7 August 2017

1 August 2002

1 reference

Expert Review of Vaccines

7 August 2017

1 reference

7 August 2017

1

1 reference

7 August 2017

2

1 reference

7 August 2017

227-232

1 reference

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

7 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

SEROLOGICAL RESPONSE TO INTRANASAL ADMINISTRATION OF INACTIVE INFLUENZA VIRUS IN CHILDREN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Diarrhoea in general practice: a sixteen-year report of investigations in a microbiology laboratory, with epidemiological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Review of intranasal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Immunostimulating complexes (ISCOMs) for nasal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Polymeric lamellar substrate particles for intranasal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Manipulating the immune system: humoral versus cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.227

21 January 2018

Identifiers

DOI

10.1586/14760584.1.2.227

1 reference

7 August 2017

1 reference

PubMed ID

12901561